2/28
01:30 am
cntx
Low
Report
2/24
06:47 am
cntx
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
High
Report
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at Lifesci Capital to a "strong-buy" rating.
2/16
01:08 am
cntx
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
Low
Report
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
2/9
08:06 am
cntx
Context Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Context Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/9
07:30 am
cntx
Context Therapeutics to Participate in Upcoming Investor Conferences
Medium
Report
Context Therapeutics to Participate in Upcoming Investor Conferences
2/8
02:05 am
cntx
Context Therapeutics (NASDAQ:CNTX) was downgraded by analysts at
Wall St
Medium
Report
Context Therapeutics (NASDAQ:CNTX) was downgraded by analysts at
Wall St
1/31
01:33 am
cntx
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
Medium
Report
Context Therapeutics (NASDAQ:CNTX) was upgraded by analysts at
Wall Stre
1/18
06:11 am
cntx
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
High
Report
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) [Yahoo! Finance]
1/16
04:05 pm
cntx
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Medium
Report
Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
12/22
08:02 am
cntx
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Jones Trading. They set a "buy" rating and a $7.00 price target on the stock.
Medium
Report
Context Therapeutics (NASDAQ:CNTX) is now covered by analysts at Jones Trading. They set a "buy" rating and a $7.00 price target on the stock.